This reassessment of BHA is the first in a larger post-market review program for food chemicals started by the Joe Biden ...

Presenting the 2026-27 Budget, the Finance Minister outlined a vision for Viksit Bharat, emphasizing sustained growth, structural reforms, and citizen empowerment. Key proposals include scaling up ...

According to a new report published by Allied Market Research, titled, "Global Oncology/Cancer Drugs Market by Drug Class Type, Indication, and Region: Global Opportunity Analysis and Industry ...

The 2028 negotiation cycle marks another major inflection point in the implementation of the Medicare Drug Price Negotiation Program—its first year incorporating Part B drugs and its first opportunity ...

The Central Drugs Standard Control Organisation (CDSCO) on Wednesday declared 167 drug samples tested by the Central and state drugs regulatory authorities as ‘not of standard quality (NSQ)' in its ...

Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development ...

Author Table of Contents Media Contact For general and media inquiries and to book our experts, please contact: ...

Today, that includes practices that exert price pressures designed to favor domestic companies, such as value-based ...

According to MarketsandMarketstm, the Tissue Diagnostics Market is projected to grow from about USD 6.74 billion in 2025 to USD 10.86 billion by 2030, at a CAGR of 10.0%. Browse 568 market data Tables ...

Headquartered in Shanghai, Arctic Vision (Cayman) Limited ("Arctic Vision"), a global ophthalmic company, announced that it has entered into an agreement to ...

Health Affairs' Rob Lott interviews Sayeh Nikpay of the University of Minnesota about her recent paper exploring how The Medicaid Drug Rebate Program and the 340B Program interact in ways that can ...

Exelixis, Inc. (Nasdaq: EXEL) today announced that its New Drug Application (NDA) for zanzalintinib, in combination with atezolizumab (Tecentriq®), has been accepted for review in the U.S. for the ...